Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2014 Sep 19;144PB:500–512. doi: 10.1016/j.jsbmb.2014.09.015

Table 1.

Ratio of ERβ to ERα protein expressions in MCF-7 and T47D cell lines treated with Res or HPIMBD for 48 h. MCF-7 and T47D breast cancer cell lines were treated with vehicle (DMSO), 50 μM Res or HPIMBD for 48 h, which is the time point of maximal induction of ERβ and maximal inhibition of ERα in these cell lines. Proteins were isolated and western blot analyses were performed. Intensities of the bands were quantified and normalized to α-tubulin. Fold changes in ERβ or ERα protein expression (Mean ± SEM) treated with Res or HPIMBD compared to vehicle-treated controls were calculated from four individual experiments and ratios of ERβ:ERα were determined

Cell line Treatment ERβ (fold change vs. control) ERα (fold change vs. control) Ratio (ERβ/ERα)
MCF-7 Resveratrol 1 0.2 5
HPIMBD 3.8 0.5 7.5
T47D Resveratrol 1.9 0.9 2.1
HPIMBD 2.9 0.3 9.6